Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug 5;58(2):2101033.
doi: 10.1183/13993003.01033-2021. Print 2021 Aug.

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment

Affiliations
Comment

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment

Mitja Jevnikar et al. Eur Respir J. .

Abstract

There is a high prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission despite a low level of clinical suspicion https://bit.ly/3ungLrQ

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M. Jevnikar has nothing to disclose. Conflict of interest: O. Sanchez reports personal fees and non-financial support from BTG, grants and personal fees from Boston Scientific, grants, personal fees and non-financial support from Bayer and BMS, personal fees from Sanofi Aventis, grants from Daiichi Sankyo, during the conduct of the study; grants, personal fees and non-financial support from MSD, grants from Boehringer Ingelheim, outside the submitted work. Conflict of interest: M. Humbert reports grants and personal fees from Actelion, personal fees from GSK and Merck, outside the submitted work. Conflict of interest: F. Parent has nothing to disclose.

Comment on

  • Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission.
    Jevnikar M, Sanchez O, Chocron R, Andronikof M, Raphael M, Meyrignac O, Fournier L, Montani D, Planquette B, Soudani M, Boucly A, Pichon J, Preda M, Beurnier A, Bulifon S, Seferian A, Jaïs X, Sitbon O, Savale L, Humbert M, Parent F. Jevnikar M, et al. Eur Respir J. 2021 Jul 20;58(1):2100116. doi: 10.1183/13993003.00116-2021. Print 2021 Jul. Eur Respir J. 2021. PMID: 33692122 Free PMC article.

References

    1. Jevnikar M, Sanchez O, Chocron R, et al. . Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission. Eur Respir J 2021; 58: 2100116. doi:10.1183/13993003.00116-2021 - DOI - PMC - PubMed
    1. Van der Hulle T, Cheung WY, Kooij S, et al. . Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet 2017; 390: 289–297. doi:10.1016/S0140-6736(17)30885-1 - DOI - PubMed
    1. Chalmers JD, Crichton ML, Goeminne PC, et al. . Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2021; 57: 2100048. doi:10.1183/13993003.00048-2021 - DOI - PMC - PubMed
    1. Penaloza A, Soulié C, Moumneh T. Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study. Lancet Haematol 2017; 4: e615–e621. doi:10.1016/S2352-3026(17)30210-7 - DOI - PubMed

LinkOut - more resources